Material and Methods
This study was conducted retrospectively. Data of patients diagnosed
with shingles between June 2017 and July 2020 were analyzed. Patients
who did not have shingles and who applied to family medicine because of
general control were accepted as the control group. The localizations of
the lesions (head and neck, thoracic, lumbosacral, extremities) of the
patients with shingles, the presence of subjective symptoms (pain,
itching), and vitamin B 12 values of both the control and study groups
were recorded. Patients who took vitamin supplements, breastfeeding and
pregnant women, children in growth and development age, those with
central and peripheral neurological diseases, those with symptoms both
pain and itching, and those using opioids and non-opioid analgesics were
excluded from the study.
The SPSS 21.0 program was used for data analysis. Frequency (n),
percentage (%), mean ± standard deviation values were used as
descriptive statistics to evaluate the data obtained from the study.
Relationships between numerical data were evaluated using
Student’s t test for independent samples when normality assumptions were
provided, and nonparametric equivalents of the same tests in cases where
normality were not be achieved. Relationships between categorical
variables were determined using the Chi‐square test. The P value
<.05 was considered statistically significant.